Paper42945003PubMed
Isolation and structure elucidation of pyridinium-type metabolites from the sponge Agelas nakamurai.
Fu CW and 6 others. J Nat Med, 2026.
Cite this record
ConductScience Library. Isolation and structure elucidation of pyridinium-type metabolites from the sponge Agelas nakamurai. Papers, record 42945003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42945003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Isolation and structure elucidation of pyridinium-type metabolites from the sponge Agelas nakamurai.
- Journal
- J Nat Med
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-27
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 107-2320-B-110-001-MY3 | Ministry of Science and Technology, Taiwan | PubMed | ||
| 110-2320-B-110-001) | Ministry of Science and Technology, Taiwan | PubMed |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39911015 | Marine natural products. | Nat Prod Rep | 2025 | https://conductscience.org/library/papers/39911015 | PubMed |
| 2 | 19096380 | Drug development from marine natural products. | Nat Rev Drug Discov | 2009 | https://conductscience.org/library/papers/19096380 | PubMed |
| 3 | 33510482 | Natural products in drug discovery: advances and opportunities. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33510482 | PubMed |
| 4 | 39952684 | Bioactives from marine resources as natural health products: A review. | Pharmacol Rev | 2025 | https://conductscience.org/library/papers/39952684 | PubMed |
| 5 | 33565317 | Marine sponge-derived/inspired drugs and their applications in drug delivery systems. | Future Med Chem | 2021 | https://conductscience.org/library/papers/33565317 | PubMed |
| 6 | 35424773 | Secondary metabolites from marine sponges of the genus Agelas: a comprehensive update insight on structural diversity and bioactivity. | RSC Adv | 2022 | https://conductscience.org/library/papers/35424773 | PubMed |
| 7 | 10579881 | Mukanadins A-C, new bromopyrrole alkaloids from marine sponge agelasnakamurai | J Nat Prod | 1999 | https://conductscience.org/library/papers/10579881 | PubMed |
| 8 | 14677933 | Ageladine A: an antiangiogenic matrixmetalloproteinase inhibitor from the marine sponge Agelas nakamurai. | J Am Chem Soc | 2003 | https://conductscience.org/library/papers/14677933 | PubMed |
| 9 | 17503838 | Nagelamide J, a novel dimeric bromopyrrole alkaloid from a sponge Agelas species. | Org Lett | 2007 | https://conductscience.org/library/papers/17503838 | PubMed |
| 10 | 20061160 | From anti-fouling to biofilm inhibition: new cytotoxic secondary metabolites from two Indonesian Agelas sponges. | Bioorg Med Chem | 2010 | https://conductscience.org/library/papers/20061160 | PubMed |
| 11 | 22360686 | Antimicrobial metabolites from the Paracel Islands sponge Agelas mauritiana. | J Nat Prod | 2012 | https://conductscience.org/library/papers/22360686 | PubMed |
| 12 | 26083682 | Structures and Biological Evaluations of Agelasines Isolated from the Okinawan Marine Sponge Agelas nakamurai. | J Nat Prod | 2015 | https://conductscience.org/library/papers/26083682 | PubMed |
| 13 | 19296638 | Nagelamides Q and R, novel dimeric bromopyrrole alkaloids from sponges Agelas sp. | Org Lett | 2009 | https://conductscience.org/library/papers/19296638 | PubMed |
| 14 | 25020256 | Agelamadins A and B, dimeric bromopyrrole alkaloids from a marine sponge Agelas sp. | Org Lett | 2014 | https://conductscience.org/library/papers/25020256 | PubMed |
| 15 | 14961668 | Novel betaines from a micronesian sponge Dysidea herbacea. | J Org Chem | 2004 | https://conductscience.org/library/papers/14961668 | PubMed |
| 16 | 28278683 | Metabolomics approach to chemical diversity of the Mediterranean marine sponge Agelas oroides. | Nat Prod Res | 2017 | https://conductscience.org/library/papers/28278683 | PubMed |
| 17 | 20353167 | Polyaxibetaine, an amino acid derivative from the marine sponge Axinella polypoides. | J Nat Prod | 2010 | https://conductscience.org/library/papers/20353167 | PubMed |
| 18 | 10444077 | Betaines and related osmoprotectants. Targets for metabolic engineering of stress resistance | Plant Physiol | 1999 | https://conductscience.org/library/papers/10444077 | PubMed |
| 19 | 23774888 | Synchronized regulation of different zwitterionic metabolites in the osmoadaption of phytoplankton. | Mar Drugs | 2013 | https://conductscience.org/library/papers/23774888 | PubMed |
| 20 | 9748394 | Novel betaines from the marine sponge Agelas dispar. | J Nat Prod | 1998 | https://conductscience.org/library/papers/9748394 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42945003
GET https://conductscience.org/api/papers/v1/42945003/references?page=2